Paracrine Factors Released from Tonsil-Derived Mesenchymal Stem Cells Inhibit Proliferation of Hematological Cancer Cells Under Hyperthermia in Co-culture Model.

Anti-tumoral activity Co-culture Hyperthermia Mesenchymal stem cells Tonsillary

Journal

Applied biochemistry and biotechnology

ISSN: 1559-0291

Titre abrégé: Appl Biochem Biotechnol

Pays: United States

ID NLM: 8208561

Informations de publication

Date de publication:
28 Oct 2023

Historique:

accepted: 17 10 2023

medline: 29 10 2023

pubmed: 29 10 2023

entrez: 28 10 2023

Statut: aheadofprint

Résumé

Mesenchymal stem cells (MSCs) are promising biological therapeutic candidates in cancer treatment. As a source of MSCs, palatine tonsil tissue is one of the secondary lymphoid organs that form an essential part of the immune system, and the relation between the secondary lymphoid organs and cancer progression leads us to investigate the effect of tonsil-derived MSCs (T-MSC) on cancer treatment. We aimed to determine the anti-tumoral effects of T-MSCs cultured at the febrile temperature (40 °C) on hematological cancer cell lines. The co-culture of cancer cells with T-MSCs was carried out under fever and normal culture conditions, and then the cell viability was determined by cell counting. In addition, apoptosis rate and cell cycle arrest were determined by flow cytometry. We confirmed the apoptotic effect of T-MSC co-culture at the transcriptional level by using real-time polymerase chain reaction (RT-PCR). We found that co-culture of cancer cells with T-MSCs significantly decreased the viable cell number under the febrile and normal culture conditions. Besides, the T-MSC co-culture induced apoptosis on K562 and MOLT-4 cells and induced the cell cycle arrest at the G2/M phase on MOLT-4 cells. The apoptotic effect of T-MSC co-culture under febrile stimulation was confirmed at the transcriptional level. Our study has highlighted the anti-tumoral effect of the cellular interaction between the T-MSCs and human hematological cancer cells during in vitro co-culture under hyperthermia.

Identifiants

DOI: 10.1007/s12010-023-04757-7 PMID: 37897623

pubmed: 37897623

doi: 10.1007/s12010-023-04757-7

pii: 10.1007/s12010-023-04757-7

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Bispo, J. A. B., Pinheiro, P. S., & Kobetz, E. K. (2020). Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harbor Perspectives in Medicine, 10(6), a034819.

pubmed: 31727680 pmcid: 7263093 doi: 10.1101/cshperspect.a034819

Zhang, C.-L., Huang, T., Wu, B.-L., He, W.-X., & Liu, D. (2017). Stem cells in cancer therapy: Opportunities and challenges. Oncotarget, 8(43), 75756.

pubmed: 29088907 pmcid: 5650462 doi: 10.18632/oncotarget.20798

Pittenger, M. F., Discher, D. E., Péault, B. M., Phinney, D. G., Hare, J. M., & Caplan, A. I. (2019). Mesenchymal stem cell perspective: Cell biology to clinical progress. NPJ Regenerative Medicine, 4(1), 1–15.

doi: 10.1038/s41536-019-0083-6

Christodoulou, I., Goulielmaki, M., Devetzi, M., Panagiotidis, M., Koliakos, G., & Zoumpourlis, V. (2018). Mesenchymal stem cells in preclinical cancer cytotherapy: A systematic review. Stem Cell Research & Therapy, 9(1), 1–38.

doi: 10.1186/s13287-018-1078-8

Hmadcha, A., Martin-Montalvo, A., Gauthier, B. R., Soria, B., & Capilla-Gonzalez, V. (2020). Therapeutic potential of mesenchymal stem cells for cancer therapy. Frontiers in Bioengineering and Biotechnology, 8, 43.

pubmed: 32117924 pmcid: 7013101 doi: 10.3389/fbioe.2020.00043

Li, T., Zhang, C., Ding, Y., Zhai, W., Liu, K., Bu, F., et al. (2015). Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway. Oncology Reports, 34(3), 1469–1477.

pubmed: 26151310 doi: 10.3892/or.2015.4109

Brenner, A. K., Nepstad, I., & Bruserud, Ø. (2017). Mesenchymal stem cells support survival and proliferation of primary human acute myeloid leukemia cells through heterogeneous molecular mechanisms. Frontiers in Immunology, 8, 106.

pubmed: 28232835 pmcid: 5299032 doi: 10.3389/fimmu.2017.00106

Wu, X.-B., Liu, Y., Wang, G.-H., Xu, X., Cai, Y., Wang, H.-Y., et al. (2016). Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation. Scientific Reports, 6(1), 1–12.

Di, G.-h, Liu, Y., Lu, Y., Liu, J., Wu, C., & Duan, H.-F. (2014). IL-6 secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells. PloS One, 9(11), e113572.

pubmed: 25419563 pmcid: 4242635 doi: 10.1371/journal.pone.0113572

Liu, C., Billet, S., Choudhury, D., Cheng, R., Haldar, S., Fernandez, A., et al. (2021). Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance. Neoplasia, 23(1), 118–128.

pubmed: 33310208 doi: 10.1016/j.neo.2020.11.012

Maj, M., Bajek, A., Nalejska, E., Porowinska, D., Kloskowski, T., Gackowska, L., et al. (2017). Influence of mesenchymal stem cells conditioned media on proliferation of urinary tract cancer cell lines and their sensitivity to ciprofloxacin. Journal of Cellular Biochemistry, 118(6), 1361–1368.

pubmed: 27873362 doi: 10.1002/jcb.25794

Dhiman, N., Shagaghi, N., Bhave, M., Sumer, H., Kingshott, P., & Rath, S. N. (2021). Indirect co-culture of lung carcinoma cells with hyperthermia-treated mesenchymal stem cells influences tumor spheroid growth in a collagen-based 3-dimensional microfluidic model. Cytotherapy, 23(1), 25–36.

pubmed: 32771259 doi: 10.1016/j.jcyt.2020.07.004

Gauthaman, K., Yee, F. C., Cheyyatraivendran, S., Biswas, A., Choolani, M., & Bongso, A. (2012). Human umbilical cord Wharton’s jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. Journal of Cellular Biochemistry, 113(6), 2027–2039.

pubmed: 22275115 doi: 10.1002/jcb.24073

Fonseka, M., Ramasamy, R., Tan, B. C., & Seow, H. F. (2012). Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) inhibit the proliferation of K562 (human erythromyeloblastoid leukaemic cell line). Cell Biology International, 36(9), 793–801.

pubmed: 22335239 doi: 10.1042/CBI20110595

Motaln, H., Gruden, K., Hren, M., Schichor, C., Primon, M., Rotter, A., et al. (2012). Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma. Cell Transplantation, 21(7), 1529–1545.

pubmed: 22554389 doi: 10.3727/096368912X640547

Fathi, E., Farahzadi, R., Valipour, B., & Sanaat, Z. (2019). Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation. PLoS One, 14(4), e0215678.

pubmed: 31009502 pmcid: 6476492 doi: 10.1371/journal.pone.0215678

Khalil, C., Moussa, M., Azar, A., Tawk, J., Habbouche, J., Salameh, R., et al. (2019). Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: An in-vitro experimental study. Journal of Ovarian Research, 12(1), 1–12.

doi: 10.1186/s13048-019-0546-9

Ayuzawa, R., Doi, C., Rachakatla, R. S., Pyle, M. M., Maurya, D. K., Troyer, D., et al. (2009). Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Letters, 280(1), 31–7.

pubmed: 19285791 pmcid: 2914472 doi: 10.1016/j.canlet.2009.02.011

Larmonier, N., Ghiringhelli, F., Larmonier, C. B., Moutet, M., Fromentin, A., Baulot, E., et al. (2003). Freshly isolated bone marrow cells induce death of various carcinoma cell lines. International Journal of Cancer, 107(5), 747–756.

pubmed: 14566824 doi: 10.1002/ijc.11463

Lim, Y.-S., Lee, J.-C., Lee, Y. S., Lee, B.-J., & Wang, S.-G. (2012). Growth inhibitory effect of palatine tonsil-derived mesenchymal stem cells on head and neck squamous cell carcinoma cells. Clinical and Experimental Otorhinolaryngology, 5(2), 86.

pubmed: 22737289 pmcid: 3380118 doi: 10.3342/ceo.2012.5.2.86

Ganta, C., Ayuzawa, R., Rachakatla, R., Pyle, M., Andrews, G., Weiss, M., et al. (2009). Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post–tumor cell inoculation. Cancer Research, 69(5), 1815–1820.

pubmed: 19244122 doi: 10.1158/0008-5472.CAN-08-2750

Zachar, L., Bačenková, D., & Rosocha, J. (2016). Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment. Journal of Inflammation Research, 9, 231.

pubmed: 28008279 pmcid: 5170601 doi: 10.2147/JIR.S121994

Akimoto, K., Kimura, K., Nagano, M., Takano, S., To’a Salazar, G., Yamashita, T., et al. (2013). Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem cells and Development, 22(9), 1370–1386.

pubmed: 23231075 doi: 10.1089/scd.2012.0486

Lu, L., Chen, G., Yang, J., Ma, Z., Yang, Y., Hu, Y., et al. (2019). Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K/AKT signaling pathway. Biomedicine & Pharmacotherapy, 112, 108625.

doi: 10.1016/j.biopha.2019.108625

Song, N., Gao, L., Qiu, H., Huang, C., Cheng, H., Zhou, H., et al. (2015). Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant. International Journal of Molecular Medicine, 36(1), 139–149.

pubmed: 25901937 pmcid: 4494598 doi: 10.3892/ijmm.2015.2191

Ramasamy, R., Lam, E. W., Soeiro, I., Tisato, V., Bonnet, D., & Dazzi, F. (2007). Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: Impact on in vivo tumor growth. Leukemia, 21(2), 304–310.

pubmed: 17170725 doi: 10.1038/sj.leu.2404489

Li, Q., Pang, Y., Liu, T., Tang, Y., Xie, J., Zhang, B., et al. (2018). Effects of human umbilical cord-derived mesenchymal stem cells on hematologic malignancies. Oncology Letters, 15(5), 6982–6990.

pubmed: 29731869 pmcid: 5920879

Zhu, Y., Sun, Z., Han, Q., Liao, L., Wang, J., Bian, C., et al. (2009). Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia, 23(5), 925–933.

pubmed: 19148141 doi: 10.1038/leu.2008.384

Lee, M. W., Park, Y. J., Kim, D. S., Park, H. J., Jung, H. L., Lee, J. W., et al. (2018). Human adipose tissue stem cells promote the growth of acute lymphoblastic leukemia cells in NOD/SCID mice. Stem Cell Reviews and Reports, 14(3), 451–460.

pubmed: 29594684 doi: 10.1007/s12015-018-9806-0

Wang, X., Ni, L., Wan, S., Zhao, X., Ding, X., Dejean, A., et al. (2020). Febrile temperature critically controls the differentiation and pathogenicity of T helper 17 cells. Immunity, 52(2), 328–41. e5.

pubmed: 32049050 doi: 10.1016/j.immuni.2020.01.006

Ha, P. T., Le, T. T. H., Bui, T. Q., Pham, H. N., Ho, A. S., & Nguyen, L. T. (2019). Doxorubicin release by magnetic inductive heating and in vivo hyperthermia-chemotherapy combined cancer treatment of multifunctional magnetic nanoparticles. New Journal of Chemistry., 43(14), 5404–5413.

doi: 10.1039/C9NJ00111E

Lim, C., Kang, J. K., Won, W. R., Park, J. Y., Han, S. M., Tn, Le., et al. (2019). Co-delivery of D-(KLAKLAK) 2 peptide and chlorin e6 using a liposomal complex for synergistic cancer therapy. Pharmaceutics, 11(6), 293.

pubmed: 31234389 pmcid: 6630662 doi: 10.3390/pharmaceutics11060293

Mues, B., Bauer, B., Roeth, A. A., Ortega, J., Buhl, E. M., Radon, P., et al. (2021). Nanomagnetic actuation of hybrid stents for hyperthermia treatment of hollow organ tumors. Nanomaterials, 11(3), 618.

pubmed: 33801426 pmcid: 7999083 doi: 10.3390/nano11030618

Goyal, U., & Ta, M. (2019). P53-NF-κB crosstalk in febrile temperature-treated human umbilical cord-derived mesenchymal stem cells. Stem Cells and Development., 28(1), 56–68.

pubmed: 30319075 doi: 10.1089/scd.2018.0115

Sen, A., & Ta, M. (2020). Altered adhesion and migration of human mesenchymal stromal cells under febrile temperature stress involves nf-κβ pathway. Scientific Reports, 10(1), 1–14.

doi: 10.1038/s41598-020-61361-z

Cho, J. A., Park, H., Kim, H. K., Lim, E. H., Seo, S. W., Choi, J. S., et al. (2009). Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line. Cancer, 115(2), 311–323.

pubmed: 19109817 doi: 10.1002/cncr.24032

Park, H., Cho, J.-A., Kim, S.-K., Kim, J.-H., & Lee, S.-H. (2008). Hyperthermia on mesenchymal stem cells (MSCs) can sensitize tumor cells to undergo cell death. International Journal of Hyperthermia, 24(8), 638–648.

pubmed: 19065344 doi: 10.1080/02656730802253117

Sánchez-Rodríguez, C., Cruces, K. P., Ayora, J. R., Martín-Sanz, E., & Sanz-Fernández, R. (2017). BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma. Vaccine, 35(47), 6395–6403.

pubmed: 29029943 doi: 10.1016/j.vaccine.2017.10.008

Mueller, S. N., & Germain, R. N. (2009). Stromal cell contributions to the homeostasis and functionality of the immune system. Nature Reviews Immunology, 9(9), 618–629.

pubmed: 19644499 pmcid: 2785037 doi: 10.1038/nri2588

Nave, H., Gebert, A., & Pabst, R. (2001). Morphology and immunology of the human palatine tonsil. Anatomy and Embryology, 204(5), 367–373.

pubmed: 11789984 doi: 10.1007/s004290100210

Smith, N., Bekaddour, N., Leboulanger, N., Richard, Y., & Herbeuval, J.-P. (2020). Isolation of tonsillar mononuclear cells to study ex vivo innate immune responses in a human mucosal lymphoid tissue. JoVE (Journal of Visualized Experiments), 160, e60914.

Yuce, M., & Albayrak, E. (2022). Hyperthermia-stimulated tonsil-mesenchymal stromal cells suppress hematological cancer cells through downregulation of IL-6. Journal of Cellular Biochemistry, 123(12), 1966–1979.

pubmed: 36029519 doi: 10.1002/jcb.30322

Oh, S.-Y., Choi, Y. M., Kim, H. Y., Park, Y. S., Jung, S.-C., Park, J.-W., et al. (2019). Application of tonsil-derived mesenchymal stem cells in tissue regeneration: Concise review. Stem Cells, 37(10), 1252–1260.

pubmed: 31287931 doi: 10.1002/stem.3058

Choi, J.-S., Lee, B.-J., Park, H.-Y., Song, J.-S., Shin, S.-C., Lee, J.-C., et al. (2015). Effects of donor age, long-term passage culture, and cryopreservation on tonsil-derived mesenchymal stem cells. Cellular Physiology and Biochemistry, 36(1), 85–99.

pubmed: 25924984 doi: 10.1159/000374055

Rieger, A. M., Nelson, K. L., Konowalchuk, J. D., & Barreda, D. R. (2011). Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. JoVE (Journal of Visualized Experiments), 50, e2597.

Albayrak, E., Uslu, M., Akgol, S., Tuysuz, E. C., & Kocabas, F. (2021). Small molecule-mediated modulation of ubiquitination and neddylation improves HSC function ex vivo. Journal of Cellular Physiology, 236(12), 8122–8136.

pubmed: 34101829 doi: 10.1002/jcp.30466

Kntayya, S. B., Ibrahim, M. D., Mohd Ain, N., Iori, R., Ioannides, C., & Abdull Razis, A. F. (2018). Induction of apoptosis and cytotoxicity by isothiocyanate sulforaphene in human hepatocarcinoma HepG2 cells. Nutrients, 10(6), 718.

pubmed: 29866995 pmcid: 6024841 doi: 10.3390/nu10060718

Kajstura, M., Halicka, H. D., Pryjma, J., & Darzynkiewicz, Z. (2007). Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete “sub-G1” peaks on DNA content histograms. Cytometry Part A: The journal of the International Society for Analytical Cytology, 71(3), 125–131.

pubmed: 17252584 doi: 10.1002/cyto.a.20357

Czene, S., Testa, E., Nygren, J., Belyaev, I., & Harms-Ringdahl, M. (2002). DNA fragmentation and morphological changes in apoptotic human lymphocytes. Biochemical and Biophysical Research Communications, 294(4), 872–878.

pubmed: 12061788 doi: 10.1016/S0006-291X(02)00588-0

McKerrell, T., & Vassiliou, G. S. (2015). Aging as a driver of leukemogenesis. Science Translational Medicine, 7(306), 306fs38-fs38.

pubmed: 26400908 pmcid: 4916992 doi: 10.1126/scitranslmed.aac4428

Hoffman, B., & Liebermann, D. (2008). Apoptotic signaling by c-MYC. Oncogene, 27(50), 6462–6472.

pubmed: 18955973 doi: 10.1038/onc.2008.312

Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., et al. (2004). Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science, 303(5660), 1010–1014.

pubmed: 14963330 doi: 10.1126/science.1092734

Zhu, H., Zhang, L., Wu, S., Teraishi, F., Davis, J. J., Jacob, D., et al. (2004). Induction of S-phase arrest and p21 overexpression by a small molecule 2 [[3-(2, 3-dichlorophenoxy) propyl] amino] ethanol in correlation with activation of ERK. Oncogene, 23(29), 4984–4992.

pubmed: 15122344 doi: 10.1038/sj.onc.1207645

Hoeferlin, L. A., Oleinik, N. V., & Krupenko, S. A. (2008). The role of CDK inhibitor p21 in anti-proliferative effects of 10-Formyltetrahydrofolate Dehydrogenase. Wiley Online Library.

doi: 10.1096/fasebj.22.1_supplement.794.3

Cousin, B., Ravet, E., Poglio, S., De Toni, F., Bertuzzi, M., Lulka, H., et al. (2009). Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS One, 4(7), e6278.

pubmed: 19609435 pmcid: 2707007 doi: 10.1371/journal.pone.0006278

Yamout, B., Hourani, R., Salti, H., Barada, W., El-Hajj, T., Al-Kutoubi, A., et al. (2010). Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study. Journal of Neuroimmunology, 227(1–2), 185–189.

pubmed: 20728948 doi: 10.1016/j.jneuroim.2010.07.013

Mancuso, P., Raman, S., Glynn, A., Barry, F., & Murphy, J. M. (2019). Mesenchymal stem cell therapy for osteoarthritis: the critical role of the cell secretome. Frontiers in Bioengineering and Biotechnology, 7, 9.

pubmed: 30761298 pmcid: 6361779 doi: 10.3389/fbioe.2019.00009

Karantalis, V., & Hare, J. M. (2015). Use of mesenchymal stem cells for therapy of cardiac disease. Circulation Research, 116(8), 1413–1430.

pubmed: 25858066 pmcid: 4429294 doi: 10.1161/CIRCRESAHA.116.303614

Joyce, N., Annett, G., Wirthlin, L., Olson, S., Bauer, G., & Nolta, J. A. (2010). Mesenchymal stem cells for the treatment of neurodegenerative disease. Regenerative Medicine, 5(6), 933–946.

pubmed: 21082892 doi: 10.2217/rme.10.72

Regmi, S., Pathak, S., Kim, J. O., Yong, C. S., & Jeong, J.-H. (2019). Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives. European Journal of Cell Biology, 98(5–8), 151041.

pubmed: 31023504 doi: 10.1016/j.ejcb.2019.04.002

Yuan, Y., Chen, D., Chen, X., Shao, H., & Huang, S. (2014). Human umbilical cord-derived mesenchymal stem cells inhibit proliferation but maintain survival of Jurkat leukemia cells in vitro by activating Notch signaling. Nan Fang Yi Ke Da Xue Xue Bao, 34(4), 441–447.

pubmed: 24752084

Tian, K., Yang, S., Ren, Q., Han, Z., Lu, S., Ma, F., et al. (2010). p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells. Cellular Physiology and Biochemistry., 26(6), 799–808.

pubmed: 21220911 doi: 10.1159/000323973

Wei, Z., Chen, N., Guo, H., Wang, X., Xu, F., Ren, Q., et al. (2009). Bone marrow mesenchymal stem cells from leukemia patients inhibit growth and apoptosis in serum-deprived K562 cells. Journal of Experimental & Clinical Cancer Research, 28(1), 1–7.

doi: 10.1186/1756-9966-28-141

Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24(5), 1294–1301.

pubmed: 16410387 doi: 10.1634/stemcells.2005-0342

Janjanin, S., Djouad, F., Shanti, R. M., Baksh, D., Gollapudi, K., Prgomet, D., et al. (2008). Human palatine tonsil: A new potential tissue source of multipotent mesenchymal progenitor cells. Arthritis Research & Therapy, 10(4), 1–12.

doi: 10.1186/ar2459

Evans, S. S., Repasky, E. A., & Fisher, D. T. (2015). Fever and the thermal regulation of immunity: The immune system feels the heat. Nature Reviews Immunology., 15(6), 335–349.

pubmed: 25976513 pmcid: 4786079 doi: 10.1038/nri3843

Cho, K.-A., Lee, H. J., Jeong, H., Kim, M., Jung, S. Y., Park, H. S., et al. (2019). Tonsil-derived stem cells as a new source of adult stem cells. World Journal of Stem Cells, 11(8), 506.

pubmed: 31523370 pmcid: 6716082 doi: 10.4252/wjsc.v11.i8.506

Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352(6333), 345–347.

pubmed: 1852210 doi: 10.1038/352345a0

Sakaguchi, Y., Sekiya, I., Yagishita, K., & Muneta, T. (2005). Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis & Rhematology, 52(8), 2521–2529.

doi: 10.1002/art.21212

Yoshimura, H., Muneta, T., Nimura, A., Yokoyama, A., Koga, H., & Sekiya, I. (2007). Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell and Tissue Research, 327(3), 449–462.

pubmed: 17053900 doi: 10.1007/s00441-006-0308-z

Wang, W., Li, L., Chen, F., & Yang, Y. (2018). Umbilical cord-derived mesenchymal stem cells can inhibit the biological functions of melanoma A375 cells. Oncology Reports, 40(1), 511–517.

pubmed: 29767256

Steiner, H., Cavarretta, I. T., Moser, P. L., Berger, A. P., Bektic, J., Dietrich, H., et al. (2006). Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328. The Prostate, 66(16), 1744–1752.

pubmed: 16998813 doi: 10.1002/pros.20492

Guo, Y., Xu, F., Lu, T., Duan, Z., & Zhang, Z. (2012). Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treatment Reviews, 38(7), 904–910.

pubmed: 22651903 doi: 10.1016/j.ctrv.2012.04.007

Reynaud, D., Pietras, E., Barry-Holson, K., Mir, A., Binnewies, M., Jeanne, M., et al. (2011). IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell, 20(5), 661–673.

pubmed: 22094259 pmcid: 3220886 doi: 10.1016/j.ccr.2011.10.012

Cozen, W., Gill, P. S., Ingles, S. A., Masood, R., Martínez-Maza, O., Cockburn, M. G., et al. (2004). IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood, 103(8), 3216–3221.

pubmed: 15070705 doi: 10.1182/blood-2003-08-2860

Lai, R., O’Brien, S., Maushouri, T., Rogers, A., Kantarjian, H., Keating, M., et al. (2002). Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Cancer, 95(5), 1071–1075.

pubmed: 12209693 doi: 10.1002/cncr.10772

Mormile, R. (2020). Hyperthermia, positive feedback loop with IL-6 and risk of NSCLC progression: A tangle to unravel? Journal of Cancer Research and Clinical Oncology, 146(4), 1101–1102.

pubmed: 31807866 doi: 10.1007/s00432-019-03105-9